Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Mometasone Furoate vs Beclomethasone Dipropionate in Seasonal Allergic Rhinitis
NCT03855189Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 1993
- Primary completion
- Oct 1993
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Organon & Co. Primary endpoints: Total Nasal Symptom Score, Number of Participants Who Experienced >=1 Adverse Event up to 31 Days and 1 more. Started Aug 1993; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03855189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855189.